HPB is a premier journal dedicated to advancing the fields of Gastroenterology and Hepatology, published by Elsevier Science Ltd. With an impressive impact factor reflective of its high-quality research output, HPB has earned its place as a Q1 journal in Gastroenterology and Q2 in Hepatology as of 2023. The journal, available in both print and electronic formats (ISSN: 1365-182X; E-ISSN: 1477-2574), serves as a vital platform for multidisciplinary research, encompassing clinical and experimental studies, aimed at improving patient care and outcomes related to liver and biliary diseases. Since its inception in 2000, HPB has published influential articles that have shaped practice and policy in the field. Located in the United Kingdom, at 125 London Wall, London EC2Y 5AS, the journal is poised to continue its mission of fostering innovation and collaboration among researchers, healthcare professionals, and academicians worldwide.

Internal Medicine is a distinguished peer-reviewed journal published by the Japan Society of Internal Medicine, focusing on the nuanced field of internal medicine. Since its inception in 1974 and with a commitment to advancing medical knowledge, the journal has evolved remarkably, aiming to disseminate high-quality research that contributes to the understanding and treatment of internal diseases. Operating from Tokyo, Japan, it provides an intellectual platform for researchers and clinicians to publish original articles, reviews, and case studies that address various aspects of internal medicine. The journal currently holds a ranking in the Q3 quartile for both Internal Medicine and miscellaneous Medicine categories as of 2023, signifying its growing influence in the medical community. Although not an open-access journal, it remains accessible to a wide audience through institutional subscriptions, enhancing its reach among professionals and students alike. With its commitment to excellence, Internal Medicine serves as an essential resource for those seeking the latest developments and research within this vital medical field.

Hepatobiliary & Pancreatic Diseases International, an esteemed journal published by Elsevier, stands as a vital resource within the field of gastroenterology and hepatology. Established in 2002, this journal has developed a significant reputation, currently ranked in the second quartile (Q2) in both categories as of 2023, showcasing its commitment to high-quality research and clinical studies. Based in Singapore, Hepatobiliary & Pancreatic Diseases International serves as an essential platform for researchers, clinicians, and healthcare professionals to share innovative findings, therapeutic approaches, and advancements in the understanding of hepatobiliary and pancreatic diseases. Although the journal does not currently offer Open Access, its rigorous peer-review process ensures that published articles maintain the highest scientific standards, fostering knowledge dissemination among the global research community. With a convergence period extending to 2024, this journal continues to play a pivotal role in enhancing the understanding and treatment of complex gastrointestinal conditions, making it a must-read for anyone engaged in this dynamic field.

Welcome to the Journal of Central Nervous System Disease, a premier Open Access publication dedicated to advancing the understanding of neurological disorders and their underlying mechanisms. Published by SAGE Publications Ltd, this esteemed journal has been serving the scientific community since 2009 and is committed to disseminating high-quality research that spans from clinical neurology to cellular and molecular neuroscience. With an impressive impact factor, the journal ranks within the top quartiles—Q2 in both Neurology and Clinical Neurology, and Q3 in Cellular and Molecular Neuroscience as of 2023. The journal's indexing in Scopus reflects its significant contribution to the field, being ranked #83 out of 400 in clinical neurology and #38 out of 97 in cellular and molecular neuroscience. This essential resource, based in the United States, is crucial for researchers, clinicians, and students looking to stay at the forefront of neurological science. By providing Open Access options, we ensure that groundbreaking research is readily available to a global audience, fostering collaboration and innovation in the study of central nervous system diseases.

Asian Biomedicine, published by WALTER DE GRUYTER GMBH, serves as a crucial platform for disseminating pioneering research in the field of biomedical sciences. Established in 2008, this journal has carved its niche in the landscape of academic publishing, concentrating on a diverse array of topics within biochemistry, genetics, and molecular biology, as well as medicine. Though it currently holds a Q4 ranking in its category, it is dedicated to fostering academic discussions and advancing knowledge among researchers, professionals, and students alike. While the journal features a variety of access options, it is committed to ensuring that its content remains relevant and impactful, with an emphasis on the latest developments and research trends. The editorial board encourages submissions that address pressing biomedical issues, thus empowering contributors to engage meaningfully with the scientific community. With a broad international scope and a focus on quality, Asian Biomedicine is poised to play an increasingly important role in the advancement of biomedical research in Asia and beyond.

The Journal of Visceral Surgery, an esteemed publication from Elsevier Masson, offers a crucial platform for disseminating innovative research in the field of visceral surgery. Operating since 2010 and continually evolving through to 2024, this journal is dedicated to presenting high-quality studies and clinical findings that advance the practice and understanding of surgical techniques and patient care in visceral surgery. With an ISSN of 1878-7886 and a notable impact within the academic community, it achieved a Q2 ranking in Medicine (miscellaneous) and a Q3 ranking in Surgery as of 2023, reflecting its growing influence in the surgical domain. Although it currently does not operate under an Open Access model, the journal remains committed to informing a diverse audience of scholars, practitioners, and students about pioneering methods, case studies, and reviews within the discipline. Positioned in France, the journal serves as an indispensable resource for enhancing surgical practice and fostering collaboration among professionals globally, making it a vital read for anyone invested in the advancement of visceral surgery.

PANCREAS, published by Lippincott Williams & Wilkins, is a preeminent journal dedicated to advancing the field of endocrinology, diabetes, hepatology, and internal medicine. With an ISSN of 0885-3177 and E-ISSN of 1536-4828, this journal aims to disseminate high-quality research findings and clinical insights that are pivotal for professionals in these areas. The journal has established itself with an impressive Q2 ranking across multiple categories in the 2023 rankings, including endocrinology, diabetes and metabolism, hepatology, and internal medicine. Although it offers no open access options, the content is meticulously curated to enrich the knowledge base of researchers and practitioners. The Scopus rankings further underscore its influence, ranking #64 in Internal Medicine and #36 in Hepatology, reflecting its commitment to scholarly excellence. Based in the United States at Two Commerce Square, 2001 Market St, Philadelphia, PA 19103, PANCREAS serves as a central hub for innovative research from 1986 to 2024, making it an essential resource for those engaged in these rapidly evolving fields.

Zentralblatt für Chirurgie is a pivotal journal in the realm of surgical medicine, serving as an essential resource for researchers, professionals, and students in the field. Published by Georg Thieme Verlag KG, this journal has been disseminating vital surgical research since its inception in 1947, fostering a robust dialogue among healthcare practitioners worldwide. While currently positioned in the Q4 quartile for both Medicine and Surgery in 2023, Zentralblatt für Chirurgie remains a valuable platform for disseminating innovative findings, case studies, and critical reviews that shape contemporary surgical practices. With a rich archive and a commitment to enhancing surgical knowledge, this journal is ideally suited for those seeking to stay abreast of current trends and developments within the medical landscape. Although it does not provide open access, its contents continue to be a crucial asset for institutions and professionals dedicated to surgical excellence.

Welcome to the Journal of Thoracic Disease, a premier scholarly journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by AME PUBLISHING COMPANY in Hong Kong, this journal has established itself as a critical platform for the dissemination of innovative research and clinical advancements since its inception in 2009. With an impressive Q2 ranking in the Scopus category of Pulmonary and Respiratory Medicine, it is recognized for its contribution to the academic community, featuring a broad range of original research, reviews, and case studies that address contemporary challenges in thoracic disease management. The journal is committed to Open Access principles, ensuring that high-quality research is readily available to a global audience, further enhancing its impact factor and reach. Researchers, healthcare professionals, and students alike will find invaluable insights within its pages, making Journal of Thoracic Disease an essential resource for those invested in the respiratory health domain.

ANTICANCER RESEARCH, published by the International Institute of Anticancer Research, stands at the forefront of cancer-related scholarly communication. With ISSN 0250-7005 and E-ISSN 1791-7530, this esteemed journal has been serving the global research community since 1981, showcasing innovative research aimed at combating cancer through various therapeutic approaches and scientific inquiry. Based in Greece, the journal aims to disseminate vital findings in the fields of Cancer Research, Medicine, and Oncology, reflecting its notable categorization in the Q3 and Q2 quartiles as of 2023. Despite its rigorous peer-review process and the absence of open access, ANTICANCER RESEARCH remains a vital publication for researchers, clinicians, and students eager to stay updated on the evolving landscape of anticancer strategies. As it converges to its milestone year of 2024, the journal continues to enrich the discourse around cancer treatment and prevention, affirming its position as an essential resource for those dedicated to advancing knowledge in anticancer therapies.